NervGen Pharma (9UA.F) Q2 2024 Earnings

16MayConfirmed
Q2 2024
-0.05
-0.04
-0.03
-0.03

Details

Expected EPS
-0.04754008
Actual EPS
-0.02716576
Surprise EPS
0.02
Surprise Percent
+42.86%

Description

NervGen Pharma (9UA.F) has reported earnings of -0.02716576 per share for Q2 2024.

0 Comments

Share your thoughts